The influence of non-response in a population-based cohort study on type 2 diabetes evaluated by the Swedish Prescribed Drug Register

European Journal of Epidemiology

Volumn 27, Issue 3, 2012, Pages 153-162

  Eriksson, Anna Karin ^a   Ekbom, Anders ^a   Hilding, Agneta ^a   Östenson, Claes Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cohort; Lifestyle; Non participation; Screening; Selection bias; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISTRESS SYNDROME; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRESCRIPTION; PREVALENCE; REGISTER; SMOKING; SOCIOECONOMICS; SWEDEN; TREATMENT RESPONSE;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SELECTION BIAS; SWEDEN;

EID: 84860306752     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9630-1     Document Type: Article

References (20)

1. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
2. Sargeant LA, Simmons RK, Barling RS, Butler R, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ. Who attends a UK diabetes screening programme? Findings from the ADDITION- Cambridge study. Diabet Med. 2010;27:995-1003.
3. Dalsgaard EM, Lauritzen T, Christiansen T, Mai KS, Borch- Johnsen K, Sandbaek A. Socioeconomic factors related to attendance at a Type 2 diabetes screening programme. Diabet Med. 2009;26:518-25.
4. Lagerlund M, Sparen P, Thurfjell E, Ekbom A, Lambe M. Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev. 2000;9:25-33. (Pubitemid 30428439)
5. Rodvall Y, Kemetli L, Tishelman C, Tornberg S. Factors related to participation in a cervical cancer screening programme in urban Sweden. Eur J Cancer Prev. 2005;14:459-66. (Pubitemid 41433644)
6. Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle characteristics among participants in a Norwegian colorectal cancer screening trial. Eur J Cancer Prev. 2006;15:10-9. (Pubitemid 43050921)
7. Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Ostenson CG. Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med. 2008;25:834-42.
8. Agardh EE, Ahlbom A, Andersson T, Efendic S, Grill V, Hallqvist J, Ostenson CG. Socio-economic position at three points in life in association with type 2 diabetes and impaired glucose tolerance in middle-aged Swedish men and women. Int J Epidemiol. 2007;36:84-92. (Pubitemid 47061579)
9. Hilding A, Eriksson AK, Agardh EE, Grill V, Ahlbom A, Efendic S, Ostenson CG. The impact of family history of diabetes and lifestyle factors on abnormal glucose regulation in middle-aged Swedish men and women. Diabetologia. 2006;49:2589-98.
10. Carlsson S, Persson PG, Alvarsson M, Efendic S, Norman A, Svanstrom L, Ostenson CG, Grill V. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middleaged men. Diabetes Care. 1999;22:1043-7. (Pubitemid 29293952)
11. Walinder O, Bergstrom I, Boethius G, Ugander L. Studies of drug-treated diabetes in the county of Jamtland, Sweden, based on prescription of insulin and oral antidiabetic drugs. Ups J Med Sci. 1986;91:89-98. (Pubitemid 16108204)
12. Forrest RD. Diabetes mellitus in north Sweden: prevalence assessed from prescriptions for anti-diabetic agents. J Intern Med. 1990;228:267-73. (Pubitemid 20330730)
13. Bergman U, Sjoqvist F. Measurement of drug utilization in Sweden: methodological and clinical implications. Acta Med Scand Suppl. 1984;683:15-22. (Pubitemid 14121289)
14. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosén M. The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16:726-35. (Pubitemid 47180362)
15. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53. (Pubitemid 28319935)
16. Statistics Sweden. Swedish socioeconomic classification. Stockholm: Statistics Sweden; 2005.
17. Stalhammar J, Berne C, Svardsudd K. Do guidelines matter? A population-based study of diabetes drug use during 20 years. Scand J Prim Health Care. 2001;19:163-9. (Pubitemid 32963953)
18. Wandell PE, Brorsson B, Aberg H. Drug prescription in diabetic patients in Stockholm in 1992 and 1995 - Change over time. Eur J Clin Pharmacol. 1997;52:249-54. (Pubitemid 27283289)
19. Cowie CC, Engelgau MM, Rust KF, Saydah SH, Byrd-Holt DD, Williams DE, Eberhardt MS, Geiss LS, Flegal KM, Gregg EW. Prevalence of diabetes and impaired fasting glucose in adults in the US population - National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263-8. (Pubitemid 44125920)
20. Juel K, Christensen K. Are men seeking medical advice too late? Contacts to general practitioners and hospital admissions in Denmark 2005. J Public Health. 2008;30:111-3.